Drugs / DLBS-32
last change Aug 2010 re-read 3 minutes ago

DLBS-32

Developed for
type 2 diabetes mellitus
Investigated by
Dexa Medica Group

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01005069 Oct 2009 → Jul 2010 type 2 diabetes mellitus Dexa Medica Group Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DLBS-32 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01005069 ↗